SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Blaser Brian J (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 05/17/2010	3. Issuer Name and Ticker or Trading Symbol ABBOTT LABORATORIES [ ABT ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Senior Vice President	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value	27,559	D
Common shares without par value	5,499(1)	I	Profit Sharing Trust

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)(2)	02/18/2008	02/17/2015	Common shares	2,157	46.34	D
Option (right to buy)(2)	02/18/2008	02/17/2015	Common shares	843	46.34	D
Option (right to buy)(2)	02/17/2008	02/16/2016	Common shares	1,900	44.16	D
Option (right to buy)(2)	02/17/2009	02/16/2016	Common shares	1,900	44.16	D
Option (right to buy)(2)	07/20/2008	07/19/2017	Common shares	1,900	53.6	D
Option (right to buy)(2)	07/20/2009	07/19/2017	Common shares	1,900	53.6	D
Option (right to buy)(2)	07/20/2010	07/19/2017	Common shares	1,900	53.6	D
Option (right to buy)(2)	02/15/2009	02/14/2018	Common shares	1,934	55.56	D
Option (right to buy)(2)	02/15/2010	02/14/2018	Common shares	1,933	55.56	D
Option (right to buy)(2)	02/15/2011	02/14/2018	Common shares	1,933	55.56	D
Option (right to buy)(2)	02/20/2010	02/19/2019	Common shares	4,267	54.14	D
Option (right to buy)(2)	02/20/2011	02/19/2019	Common shares	4,267	54.14	D
Option (right to buy)(2)	02/20/2012	02/19/2019	Common shares	4,266	54.14	D
Option (right to buy)(3)	02/19/2011	02/18/2020	Common shares	3,234	54.5	D
Option (right to buy)(3)	02/19/2012	02/18/2020	Common shares	3,233	54.5	D
Option (right to buy)(3)	02/19/2013	02/18/2020	Common shares	3,233	54.5	D
Option (right to buy)(3)	05/17/2011	05/16/2020	Common shares	6,334	48.34	D
Option (right to buy)(3)	05/17/2012	05/16/2020	Common shares	6,333	48.34	D
Option (right to buy)(3)	05/17/2013	05/16/2020	Common shares	6,333	48.34	D

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of May 25, 2010.

2. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

3. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

	John A. Berry, by power of attorney for Brian J. Blaser	05/27/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.